Pharming Group NV (PHAR)
12.59
0.00 (0.00%)
USD |
NASDAQ |
Jun 10, 15:45
Pharming Group EPS Diluted (Quarterly) : -0.0746 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ProQR Therapeutics NV | -0.1486 |
| NewAmsterdam Pharma Co. NV | -0.398 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alkermes Plc | -0.40 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.232M |
| Revenue (Quarterly) | 72.71M |
| Total Expenses (Quarterly) | 77.94M |
| Enterprise Value | 828.37M |
| Gross Profit Margin (Quarterly) | 90.83% |
| Profit Margin (Quarterly) | -7.20% |
| Earnings Yield | 1.37% |
| Operating Earnings Yield | 3.55% |
| Normalized Earnings Yield | 2.179 |